Drug Profile
Monoclonal antibody OC 125
Latest Information Update: 14 Jul 1998
Price :
$50
*
At a glance
- Originator Centocor
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Ovarian cancer
Most Recent Events
- 14 Jul 1998 Profile reviewed
- 14 Jul 1998 No-Development-Reported for Cancer in Germany (Unknown route)
- 14 Jul 1998 No-Development-Reported for Ovarian cancer in USA (Intraperitoneal)